CHILI 6.0
CHILI – the Conference on Hybrid Imaging Live – will return with its engaging format on November 17, 2023. A full day of hybrid imaging awaits you. It will again be streamed online only and will be free of charge for everyone.
A professional studio, live moderation and live speakers will make CHILI stand out from other online conferences with pre-recorded talks from the can.
CHILI is live, CHILI is fresh, CHILI is spicy.
| 08:30-08:35 | Introduction to CHILI 6.0 |
| ONCOLOGY 1 | |
| 08:35-08:55 | Hybrid imaging for radiation therapy planning |
| 08:55-09:15 | Hybrid imaging for therapy management of head and neck tumours |
| 09:15-09:35 | Neuroendocrine tumours diagnostics and theranostics |
| 09:35-10:00 |
Discussion and Q&A with the experts MODERATION: CLEMENS CYRAN, GERMANY & THOMAS BEYER, AUSTRIA |
| 10:00 10:15 | Break |
| HEART AND BRAIN | |
| 10:15-10:35 | PET MR in cardiac imaging |
| 10:35-10:55 | New therapeutic options for dementia - A new role for hybrid imaging? |
| 10:55-11:15 | Brain Tumour management with hybrid imaging |
| 11:15-11:40 |
Discussion and Q&A with the experts |
| 11:40-12:00 | Break |
| SPONSORED SYMPOSIUM & DISCUSSION | |
| 12:30-12:45 | Break |
| INFECTION AND INFLAMMATION | |
| 12:45-13:05 | Infections and Fever of unknown origin |
| 13:05-13:25 | Inflammation of orthopedic prosthesis |
| 13:25-13:45 | Hybrid imaging in rheumatic disorders |
| 13:45-14:05 |
Discussion and Q&A with the experts |
| 14:05-14:20 | Break |
| SPONSORED SYMPOSIUM & DISCUSSION | |
| 14:50-15:05 | Break |
| ONCOLOGY 2 | |
| 15:05-15:25 | FAPI diagnostic and theranostics in oncology |
| 15:25-15:45 | PSMA in prostate cancer management |
| 15:45-16:05 | cMET Hybrid Imaging in renal cancer |
| 16:05-16:25 |
Discussion and Q&A with the experts |
| 16:25-16:40 | Break |
| NEW HORIZONS FOR HYBRID IMAGING | |
| 16:40-17:00 | Hybrid imaging for inter-organ communication |
| 17:00-17:20 | The five future key applications of AI in Hybrid Imaging |
| 17:20-17:40 | Future of Hybrid Imaging |
| 17:40-18:00 |
Discussion and Q&A with the experts |